InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
无可用的信号评分。
Discover the detailed record of transactions filed by Yu De-Chao Michael, 管理人员. Insider active across 1 company, notably Innovent Biologics, Inc.. In total, 2 disclosures have been logged. History available since 11 May 2026. The latest transaction was disclosed on 11 May 2026 (Sale). Regulator: HKEX. All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Yu De-Chao Michael is an executive at Innovent Biologics, Inc., where he plays a key role in the management and strategy of the company. He is responsible for aligning operations with strategic objectives, thus contributing to the growth and efficiency of the organization. His expertise in the biopharmaceutical sector is an asset for Innovent Biologics.